Chart calendar DaShenLin Pharmaceutical Group Co., Ltd.

858eb63296bdbe87ac5a3e7c20b5655d.__Ovifo-YkwmeQvNgENyKq9aCVJtOJBIs5a4yitaA5E.u7vY8JtpM3x_CliF8w4-E8I3SAQbXNk56cDfnVtoWdmmxfXxiwhQOxMORg~e7f6a9a80a236af90be668f028efa373

Upcoming events on DaShenLin Pharmaceutical Group Co., Ltd.

22/04/2026

Q1 2026 Earnings Release (Projected)

23/04/2026

Q4 2025 Earnings Release

01/09/2026

Q2 2026 Earnings Release (Projected)

28/10/2026

Q3 2026 Earnings Release (Projected)

28/04/2027

Q1 2027 Earnings Release (Projected)

Past events on DaShenLin Pharmaceutical Group Co., Ltd.

29/10/2025

Q3 2025 Earnings Release

28/08/2025

Q2 2025 Earnings Release

28/04/2025

Q4 2024 Earnings Release

25/04/2025

Q1 2025 Earnings Release

30/10/2024

Q3 2024 Earnings Release

18/07/2024

Extraordinary Shareholders Meeting

20/05/2024

Annual General Meeting

28/04/2024

Q4 2023 Earnings Release

27/04/2024

Q1 2024 Earnings Release

01/04/2024

Extraordinary Shareholders Meeting

08/02/2024

Extraordinary Shareholders Meeting

29/12/2023

Extraordinary Shareholders Meeting

30/10/2023

Q3 2023 Earnings Release

29/08/2023

Q2 2023 Earnings Release

19/05/2023

Annual General Meeting

27/04/2023

Q4 2022 Earnings Release

27/04/2023

Q1 2023 Earnings Release

12/04/2023

Extraordinary Shareholders Meeting

13/03/2023

Extraordinary Shareholders Meeting

03/02/2023

Extraordinary Shareholders Meeting

Past dividends on DaShenLin Pharmaceutical Group Co., Ltd.

05/11/2025

Interim Payment 0.34 CNY

18/06/2025

Final Payment 0.31 CNY

22/10/2024

Interim Payment 0.31 CNY

20/06/2024

Annual 0.31 CNY

08/06/2023

Annual 0.6 CNY

12/06/2022

Annual 0.5 CNY

09/06/2021

Annual 0.8 CNY

16/06/2020

Annual 0.6 CNY

29/05/2019

Annual 0.6 CNY

18/06/2018

Annual 0.6 CNY

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million CNY
Released
Forecast
Spread
21 248
20 468
3.81%
24 531
24 720
-0.76%
26 497
26 779
-1.05%

27 582


30 825


33 849

EBITDA
Million CNY
Released
Forecast
Spread
1 883
2 263
-16.81%
2 119
2 532
-16.31%
3 395
3 349
1.4%

3 272


3 732


4 333

EBIT
Million CNY
Released
Forecast
Spread
1 421
1 493
-4.85%
1 632
1 868
-12.66%
1 501
1 673
-10.32%

1 872


2 195


2 602

Earnings before Tax (EBT)
Million CNY
Released
Forecast
Spread
1 415
1 477
-4.18%
1 628
1 807
-9.91%
1 340
1 496
-10.42%

1 693


2 060


2 437

Net income
Million CNY
Released
Forecast
Spread
1 036
1 098
-5.65%
1 166
1 303
-10.51%
915
1 152
-20.57%

1 180


1 435


1 695

EPS
CNY
Released
Forecast
Spread
0,91
0,98
-7.38%
1,03
1,15
-10.59%
0,81
1,05
-23.07%

1,03


1,26


1,49

Announcement Date27/04/2328/04/2425/04/25-

Quarterly results

Fiscal PeriodSeptember 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4 2027 Q1 2027 Q2 2027 Q3
Net sales
Million CNY
Released
Forecast
Spread
6 752
6 842
-1.32%
6 593
7 259
-9.17%
6 386
6 364
0.34%
6 766
7 282
-7.09%
6 956
7 159
-2.84%
6 567
7 200
-8.79%
6 546
6 554
-0.12%

7 280


7 227


7 270


7 445


7 702


7 746


8 419


8 419

EBITDA
Million CNY
Released
Forecast
Spread
571
930
-38.59%

953


851


613


827


882


791


621


1 057


1 008


1 113


484


1 181


1 132


1 253

EBIT
Million CNY
Released
Forecast
Spread
571
541
5.61%
369
618
-40.34%
295
422
-30.2%
230


650


476
403
18%
410
330
24.26%

196


569


535


612


73,9


752


702


824

Earnings before Tax (EBT)
Million CNY
Released
Forecast
Spread
572
509
12.27%
329
498
-33.97%
278
384
-27.52%
160
146
10%
649
362
79.29%
474
404
17.44%
398
314
26.73%

153


641


592


697


67,4


740


689


811

Net income
Million CNY
Released
Forecast
Spread
398
470
-15.22%
259
357
-27.39%
201
275
-27.16%
56,6
75,8
-25.28%
460
255
80.19%
338
276
22.59%
283
192
47%

91,6


503


442


547


-94,2


578


514


635

EPS
CNY
Released
Forecast
Spread
0,35
0,32
10.79%
0,23
0,36
-36.31%
0,18
0,24
-24.13%
0,06
0,11
-44.88%
0,40
0,31
29.85%
0,30
0,24
22.92%
0,25
0,18
39.3%

0,07


0,38


0,31


0,34


0,11


0,51


0,45


0,56

Announcement Date28/04/2430/08/2430/10/2425/04/2525/04/2528/08/2529/10/25--------
12/02/2026

Q3 2025 Earnings Release

19/02/2026

January 2026 Sales and Revenue Release

03/03/2026

Q4 2025 Earnings Release

03/03/2026

Q4 2025 Earnings Release

11/03/2026

Q4 2025 Earnings Release

15/03/2026

Q4 2025 Earnings Release (Projected)

19/03/2026

February 2026 Sales and Revenue Release

22/03/2026

Q4 2025 Earnings Release (Projected)

25/03/2026

Q2 2026 Earnings Release (Projected)

29/03/2026

Q4 2025 Earnings Release (Projected)

Past sector events for DaShenLin Pharmaceutical Group Co., Ltd.

04/02/2026

Q4 2025 Earnings Release

30/01/2026

Q3 2026 Earnings Release

26/01/2026

Q2 2025 Earnings Release

19/01/2026

December 2025 Sales and Revenue Release

13/01/2026

Q3 2025 Earnings Release (Projected)

31/12/2025

Q1 2026 Earnings Release (Projected)

21/12/2025

November 2025 Sales and Revenue Release

29/11/2025

Q3 2025 Earnings Release

26/11/2025

Q2 2026 Earnings Release

20/11/2025

October 2025 Sales and Revenue Release

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 603233 Stock
  4. Calendar DaShenLin Pharmaceutical Group Co., Ltd.